Data Availability
The data underlying this article will be shared on reasonable request to the corresponding author.
References
Anderson CW, Bennett JJ. Clinical presentation and diagnosis of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am. 2016;25(2):363–74. https://doi.org/10.1016/j.soc.2015.12.003.
Maggio I, Mollica V, Brighi N, Lamberti G, Manuzzi L, Ricci AD, et al. The functioning side of the pancreas: a review on insulinomas. J Endocrinol Invest. 2020;43(2):139–48. https://doi.org/10.1007/s40618-019-01091-w.
Prosperi D, Gentiloni SG, Panzuto F, Faggiano A, Russo VM, Caruso D, et al. Nuclear medicine and radiological imaging of pancreatic neuroendocrine neoplasms: a multidisciplinary update. J Clin Med. 2022;11(22):6836. https://doi.org/10.3390/jcm11226836.
Luo Y, Chen X. Imaging of insulinoma by targeting glucagonlike peptide-1 receptor. PET Clin. 2021;16(2):205–17. https://doi.org/10.1016/j.cpet.2020.12.008.
Pattison DA, Hicks RJ. Molecular imaging in the investigation of hypoglycaemic syndromes and their management. Endocr Relat Cancer. 2017;24(6):R203–21. https://doi.org/10.1530/ERC-17-0005.
Funding
This report was funded by National Natural Science Foundation of China (Grant number 82071961), and the medical and health guiding project in Xiamen (Grant number 3502Z20224ZD1001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent and ethical approval
This study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital of Xiamen University, and written informed consent for publication of this report was obtained from the patient.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Oncology - General
Rights and permissions
About this article
Cite this article
Guo, W., Chen, Y., He, X. et al. [68 Ga]Ga-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma. Eur J Nucl Med Mol Imaging 50, 2910–2911 (2023). https://doi.org/10.1007/s00259-023-06182-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06182-8